Getein Biotech Inc Strategic Asset Allocation Index
Getein Biotech Inc strategic asset allocation index. Getein Biotech Inc (603387) has a Strategic Asset Allocation Index of 21.9% as of June 2023. Strategic assets (PP&E of CN¥584.64 Million plus long-term investments of CN¥-) total CN¥584.64 Million, measured against net assets of CN¥2.67 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Getein Biotech Inc balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Getein Biotech Inc (2012–2022)
Strategic asset allocation index of Getein Biotech Inc from 2012 to 2022. This chart shows how Getein Biotech Inc's Strategic Asset Allocation Index has evolved across 10 annual periods from 2012 to 2022. As of June 2023, the index stands at 21.9%, representing strategic assets of CN¥584.64 Million against net assets of CN¥2.67 Billion CNY. Check Getein Biotech Inc (603387) tangible net worth to evaluate the tangible quality of the company's equity base.
Getein Biotech Inc Strategic Asset Allocation Index by Year (2012–2022)
Getein Biotech Inc strategic asset allocation index by year from 2012 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Getein Biotech Inc from 2012 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Getein Biotech Inc.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 20.9% | CN¥556.49 Million | CN¥556.49 Million | CN¥- | CN¥2.66 Billion | ▲ +1.0 pp |
| 2021 | 19.9% | CN¥452.20 Million | CN¥452.20 Million | CN¥- | CN¥2.27 Billion | ▲ +1.4 pp |
| 2020 | 18.4% | CN¥369.63 Million | CN¥369.63 Million | CN¥- | CN¥2.00 Billion | ▲ +0.8 pp |
| 2019 | 17.6% | CN¥296.75 Million | CN¥296.75 Million | CN¥- | CN¥1.68 Billion | ▲ +0.9 pp |
| 2018 | 16.7% | CN¥231.35 Million | CN¥231.35 Million | CN¥- | CN¥1.38 Billion | ▲ +1.5 pp |
| 2017 | 15.2% | CN¥174.87 Million | CN¥174.87 Million | CN¥- | CN¥1.15 Billion | ▼ -20.5 pp |
| 2016 | 35.7% | CN¥122.49 Million | CN¥122.49 Million | CN¥- | CN¥342.96 Million | ▼ -6.4 pp |
| 2014 | 42.2% | CN¥69.65 Million | CN¥69.65 Million | CN¥- | CN¥165.19 Million | ▼ -25.0 pp |
| 2013 | 67.1% | CN¥56.42 Million | CN¥56.42 Million | CN¥- | CN¥84.06 Million | ▼ -26.8 pp |
| 2012 | 94.0% | CN¥38.18 Million | CN¥38.18 Million | CN¥- | CN¥40.63 Million | — |